350 related articles for article (PubMed ID: 25197808)
1. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency.
Han F; Lin L; Schormair B; Pizza F; Plazzi G; Ollila HM; Nevsimalova S; Jennum P; Knudsen S; Winkelmann J; Coquillard C; Babrzadeh F; Strom TM; Wang C; Mindrinos M; Fernandez Vina M; Mignot E
Sleep; 2014 Oct; 37(10):1601-8. PubMed ID: 25197808
[TBL] [Abstract][Full Text] [Related]
2. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
[TBL] [Abstract][Full Text] [Related]
3. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
[TBL] [Abstract][Full Text] [Related]
4. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
[TBL] [Abstract][Full Text] [Related]
5. HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy.
Jeong JH; Hong SC; Shin YK; Han JH; Lee SP
J Korean Med Sci; 2007 Feb; 22(1):127-31. PubMed ID: 17297265
[TBL] [Abstract][Full Text] [Related]
6. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
[TBL] [Abstract][Full Text] [Related]
7. A series of 7 cases of patients with narcolepsy with hypocretin deficiency without the HLA DQB1*06:02 allele.
Miano S; Barateau L; De Pieri M; Riccardi S; Thevenin C; Manconi M; Dauvilliers Y
J Clin Sleep Med; 2023 Dec; 19(12):2053-2057. PubMed ID: 37539640
[TBL] [Abstract][Full Text] [Related]
8. [Positivity analysis of human leukocyte histocompatibility antigen-DQB1*0602 allele in Chinese patients with narcolepsy].
Li J; Dong X; Yan H; Liu Y; An P; Zhao L; Li Q; Zhang X; Gao Z; Han F
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):763-5. PubMed ID: 24844961
[TBL] [Abstract][Full Text] [Related]
9. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.
Heier MS; Evsiukova T; Vilming S; Gjerstad MD; Schrader H; Gautvik K
Sleep; 2007 Aug; 30(8):969-73. PubMed ID: 17702265
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.
Andlauer O; Moore H; Jouhier L; Drake C; Peppard PE; Han F; Hong SC; Poli F; Plazzi G; O'Hara R; Haffen E; Roth T; Young T; Mignot E
JAMA Neurol; 2013 Jul; 70(7):891-902. PubMed ID: 23649748
[TBL] [Abstract][Full Text] [Related]
11. A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1.
Dauvilliers Y; Maret S; Bassetti C; Carlander B; Billiard M; Touchon J; Tafti M
Neurology; 2004 Jun; 62(11):2137-8. PubMed ID: 15184641
[No Abstract] [Full Text] [Related]
12. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of typical cataplexy+ DQB1*0602 positive to hypocretin-1 reduction in cerebrospinal fluid in patients with narcolepsy].
Chang Y; Dong XS; Li J; Zhang XZ; Yan H; Zhang W; Zhao L; Zuo YH; Yu YB; Dou YL; Feng JJ; Han F
Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(40):3253-3257. PubMed ID: 30392291
[No Abstract] [Full Text] [Related]
14. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups.
Mignot E; Lin L; Rogers W; Honda Y; Qiu X; Lin X; Okun M; Hohjoh H; Miki T; Hsu S; Leffell M; Grumet F; Fernandez-Vina M; Honda M; Risch N
Am J Hum Genet; 2001 Mar; 68(3):686-99. PubMed ID: 11179016
[TBL] [Abstract][Full Text] [Related]
15. HLA-DQ association and allele competition in Chinese narcolepsy.
Han F; Lin L; Li J; Dong SX; An P; Zhao L; Liu NY; Li QY; Yan H; Gao ZC; Faraco J; Strohl KP; Liu X; Miyadera H; Mignot E
Tissue Antigens; 2012 Oct; 80(4):328-35. PubMed ID: 22862152
[TBL] [Abstract][Full Text] [Related]
16. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
[TBL] [Abstract][Full Text] [Related]
17. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
[TBL] [Abstract][Full Text] [Related]
18. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.
Savvidou A; Knudsen S; Olsson-Engman M; Gammeltoft S; Jennum P; Palm L
Sleep; 2013 Jan; 36(1):147-8. PubMed ID: 23288981
[TBL] [Abstract][Full Text] [Related]
19. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia].
MartÃnez-RodrÃguez JE; Iranzo A; Casamitjana R; Graus F; Santamaria J
Med Clin (Barc); 2007 Mar; 128(10):361-4. PubMed ID: 17386240
[TBL] [Abstract][Full Text] [Related]
20. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
